A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women.


Journal

Cancer prevention research (Philadelphia, Pa.)
ISSN: 1940-6215
Titre abrégé: Cancer Prev Res (Phila)
Pays: United States
ID NLM: 101479409

Informations de publication

Date de publication:
04 2019
Historique:
received: 08 06 2018
revised: 12 11 2018
accepted: 29 01 2019
pubmed: 7 2 2019
medline: 14 7 2020
entrez: 7 2 2019
Statut: ppublish

Résumé

To examine the association between metabolic deregulation and pancreatic cancer, we conducted a two-stage case-control targeted metabolomics study using prediagnostic sera collected one year before diagnosis in the Women's Health Initiative study. We used the LC/MS to quantitate 470 metabolites in 30 matched case/control pairs. From 180 detectable metabolites, we selected 14 metabolites to be validated in additional 18 matched case/control pairs. We used the paired

Identifiants

pubmed: 30723176
pii: 1940-6207.CAPR-18-0201
doi: 10.1158/1940-6207.CAPR-18-0201
pmc: PMC6445762
mid: NIHMS1520874
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-246

Subventions

Organisme : HSRD VA
ID : I50 HX001236
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA172880
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100046C
Pays : United States
Organisme : WHI NIH HHS
ID : N01WH42129
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01WH32118
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA125123
Pays : United States
Organisme : WHI NIH HHS
ID : N01WH32108
Pays : United States
Organisme : WHI NIH HHS
ID : N01WH32100
Pays : United States
Organisme : WHI NIH HHS
ID : N01WH22110
Pays : United States
Organisme : WHI NIH HHS
ID : N01WH24152
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01WH42107
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA220297
Pays : United States
Organisme : WHI NIH HHS
ID : N01WH32119
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600018C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01WH32105
Pays : United States
Organisme : WHI NIH HHS
ID : N01WH32111
Pays : United States
Organisme : WHI NIH HHS
ID : N01WH32115
Pays : United States
Organisme : WHI NIH HHS
ID : N01WH44221
Pays : United States

Informations de copyright

©2019 American Association for Cancer Research.

Références

Oncotarget. 2018 May 1;9(33):23078-23090
pubmed: 29796173
J Natl Cancer Inst. 2019 Apr 1;111(4):372-379
pubmed: 30137376
Clin Biochem. 2012 Sep;45(13-14):1064-9
pubmed: 22613268
Oncotarget. 2017 Aug 18;8(40):68899-68915
pubmed: 28978166
Nat Protoc. 2012 Apr 12;7(5):872-81
pubmed: 22498707
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S415-23
pubmed: 23096698
Carcinogenesis. 2014 Jul;35(7):1441-50
pubmed: 24743516
Clin Cancer Res. 2013 Sep 15;19(18):4983-93
pubmed: 23918603
Biomark Med. 2016 Jun;10(6):577-86
pubmed: 27171159
Oncotarget. 2017 Apr 25;8(17):29116-29124
pubmed: 28418859
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4410-7
pubmed: 26216984
Cancer Lett. 2015 Jan 28;356(2 Pt A):176-83
pubmed: 24262660
Clin Chim Acta. 2017 May;468:98-104
pubmed: 28215548
Gastroenterology. 2018 Nov;155(5):1474-1482.e1
pubmed: 30076838
Cancer Metab. 2017 Jan 30;5:2
pubmed: 28163917
Indian J Surg Oncol. 2011 Jun;2(2):88-100
pubmed: 22693400
Pancreas. 2012 Apr;41(3):474-80
pubmed: 22422139
J Am Coll Surg. 2008 May;206(5):849-54; discussion 854-6
pubmed: 18471709
Nat Med. 2014 Oct;20(10):1193-1198
pubmed: 25261994
Future Oncol. 2008 Feb;4(1):93-102
pubmed: 18241004
Appl Biochem Biotechnol. 2011 Sep;165(1):148-54
pubmed: 21505807
Cancer Res. 2011 Dec 15;71(24):7376-86
pubmed: 21990318
Amino Acids. 2016 Jun;48(6):1339-45
pubmed: 27033065
Metabolomics. 2013 Jun;9(3):677-687
pubmed: 23678345
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):571-9
pubmed: 23542803
Ann Epidemiol. 2003 Oct;13(9 Suppl):S18-77
pubmed: 14575939
Gut. 2018 Jan;67(1):128-137
pubmed: 28108468
Med Oncol. 2016 Dec;33(12):133
pubmed: 27807722
J Proteome Res. 2015 Feb 6;14(2):1195-202
pubmed: 25429707
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):140-7
pubmed: 21098649
Genome Med. 2016 Apr 21;8(1):46
pubmed: 27102537
J Proteome Res. 2012 Feb 3;11(2):1274-83
pubmed: 22066465
J Physiol Pharmacol. 2015 Oct;66(5):711-8
pubmed: 26579577
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
J Biol Regul Homeost Agents. 2018 Jan-Feb;32(1):75-82
pubmed: 29504368
World J Gastroenterol. 2014 Oct 7;20(37):13325-42
pubmed: 25309068
Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2182-201
pubmed: 24096148
J Biol Chem. 2017 May 26;292(21):8560-8568
pubmed: 28389555
JOP. 2009 Mar 09;10(2):104-8
pubmed: 19287101
Sci Rep. 2016 Dec 21;6:38885
pubmed: 28000704
BMC Cancer. 2013 Sep 12;13:416
pubmed: 24024929
Int J Cancer. 2018 Nov 1;143(9):2161-2167
pubmed: 29717485
PLoS One. 2015 Jul 02;10(7):e0132223
pubmed: 26133769
Rapid Commun Mass Spectrom. 2010 Mar 15;24(5):613-20
pubmed: 20143319

Auteurs

Li Jiao (L)

Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas. jiao@bcm.edu.
Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas.
Advanced Technology Core, Baylor College of Medicine, Houston, Texas.
Department of Molecular & Cell Biology, Baylor College of Medicine, Houston, Texas.
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Suman Maity (S)

Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.

Cristian Coarfa (C)

Advanced Technology Core, Baylor College of Medicine, Houston, Texas.
Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.

Kimal Rajapakshe (K)

Texas Medical Center Digestive Disease Center, Houston, Texas.

Liang Chen (L)

Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas.

Feng Jin (F)

Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.

Vasanta Putluri (V)

Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.

Lesley F Tinker (LF)

Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey VA Medical Center, Houston, Texas.

Qianxing Mo (Q)

Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.

Fengju Chen (F)

Advanced Technology Core, Baylor College of Medicine, Houston, Texas.

Subrata Sen (S)

Department of Translational Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

Haleh Sangi-Hyghpeykar (H)

Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas.

Hashem B El-Serag (HB)

Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas.
Advanced Technology Core, Baylor College of Medicine, Houston, Texas.
Department of Molecular & Cell Biology, Baylor College of Medicine, Houston, Texas.

Nagireddy Putluri (N)

Advanced Technology Core, Baylor College of Medicine, Houston, Texas.
Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.
Texas Medical Center Digestive Disease Center, Houston, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH